Infant Phototherapy Device Market is expected to reach a value of US$ 117.80 Million by 2027

Renub Research has recently published a report named "Infant Phototherapy Device Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2027," providing a detailed industry analysis that consists of market share insights. Furthermore, the report encompasses a study of competitors and regions and the recent growth in the Infant Phototherapy Device Market.

Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/infant-phototherapy-device-market-p.php

Infant Phototherapy Device Market growth will accelerate from 2022 to 2028 at a CAGR of 4.44%. Infant phototherapy devices, through the use of light therapy, effectively treat neonatal jaundice by oxidizing bilirubin in the child's blood. They mitigate the neurotoxic consequences of elevated serum levels of unconjugated bilirubin and lessen the requirement for exchange transfusion in newborns. Infant phototherapy devices, equipped with hour meters, are placed under or near the baby, commonly used in hospitals and nursing homes globally for their effectiveness and affordability.

Neonatal jaundice is becoming more common, which is driving up the need for infant phototherapy. According to NCBI, clinical jaundice appears in the first week following birth in about 60% of term and 80% of preterm neonates. Increased parental and medical professional knowledge of phototherapy's advantages in the management of newborn jaundice also contributes to the market's expansion. The increased demand for efficient and non-invasive therapeutic options is another factor fueling the demand.

It is anticipated that businesses investing in control panel phototherapy devices and user-friendly blue spectrum radiation sources will benefit from the growing technical developments. Because LED radiation sources may be controlled for radiation intensity and use little power, major stakeholders are consistently working on them. To avoid infrared and ultraviolet radiation, several businesses in the newborn phototherapy devices market are largely concentrating on gadgets with a peak wavelength of 460 nm that can be put atop an incubator or a warmer.

The rise of quartz halogen lamps is due to their efficiency in curing jaundice in infants.

High-intensity blue-green light provided by quartz halogen lamps is generally beneficial for infants who have been diagnosed with newborn jaundice. In addition to efficiently reducing bilirubin in the baby's blood, these lamps are more durable and energy-efficient than conventional phototherapy lamps. The market for quartz halogen lamps used in newborn phototherapy is anticipated to experience significant expansion due to the rising incidence of neonatal jaundice and the demand for safer and more efficient treatment options.

The newborn phototherapy market is dominated by mobile device configuration.

Mobile devices' predominance in infant phototherapy can be attributed to their portability and ease of use, which enables medical professionals to administer the therapy right at the child's bedside, obviating the need to move the infant to a different treatment area and enabling closer supervision throughout the therapy session. To fulfill the unique demands of each newborn, mobile devices also provide flexibility in modifying the light intensity and length of the therapy.

Neonatal clinics are now more necessary than ever because of the early identification and treatment of newborn jaundice.

The care of neonates with jaundice is crucially handled by neonatal clinics. Modern technology and their highly qualified medical team make it possible to successfully diagnose and treat this problem. In these specialist clinics, premature newbornswho are more vulnerable to jaundice and other medical conditions are also cared for. Neonatal clinics are growing in number as the demand for specialist care and modern healthcare facilities rises, especially in emerging nations with higher infant death rates. Their commitment to caring for and defending our youngest patients is very admirable.

One of the most important regions in the Infant Phototherapy Device Market is North America.

Neonatal jaundice is more common in North America than in other places due to higher rates of preterm deliveries and breastfeeding, which helps explain its market dominance for newborn phototherapy. Furthermore, the region gains from the availability of cutting-edge and safer phototherapy equipment, vigorous research and development initiatives, government assistance, high disposable incomes of parents, strong demand for cutting-edge products, and the presence of significant industry participants. These elements work together to explain why North America continues to dominate the newborn phototherapy market.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=infant-phototherapy-device-market-p.php

Competitive Landscape.

Koninklijke Philips N.V., Natus Medical Incorporated, Ningbo David Medical Device Co., Ltd., Becton, Dickson, and Company, Inspiration Healthcare Group Plc., Atom Medical Corporation, Drägerwerk AG & Co. KGaA, and Nihon Kohdenare a few of the main players in the Infant Phototherapy Device Market.

Market Summary:

• Type - The Report covers Infant Phototherapy Device Market, bytypein 4 viewpoints (Light Emitting Diodes (LED), Fluorescent Lamps (FL), Quartz Halogen Lamps, and Gas Discharge Tubes).
• Configuration - Infant Phototherapy Device Market, by configuration, breakup in 2 viewpoints (mobile devices and fixed devices).
• End-User - The Report covers Infant Phototherapy Device Market, by end-userin 2 viewpoints (hospitals and neonatal clinics).
• Region - By region, the Infant Phototherapy Device Market, breakup in 4 viewpoints (Europe, North America, Asia-Pacific, and the Rest of the World).

• Key Players- All the major players have been covered from 3 Viewpoints (Overview, Recent Developments, and Revenue) Johnson Controls Revenue, Schneider Electric, Emerson Electric Revenue, LG, LeGrand, Siemens AG, Honeywell, and Apple.

Related Reports

Telemedicine Market: https://www.renub.com/telemedicine-market-p.php
Age-Related Macular Degeneration Market: https://www.renub.com/age-related-macular-degeneration-market-p.php
Hip Replacement Market: https://www.renub.com/hip-replacement-market-global-forecast-p.php
Hair Transplant Market: https://www.renub.com/hair-transplant-market-p.php
Orthopedic Implants Market: https://www.renub.com/orthopaedic-implants-market-p.php

About the Company:

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://in.linkedin.com/company/renub-research
Web: www.renub.com

This release was published on openPR.